Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.

International journal of cardiology - 1 Jan 2015

Zabarovskaja Stanislava, Hage Camilla, Linde Cecilia, Daubert Jean-Claude, Donal Erwan, Gabrielsen Anders, Mellbin Linda, Lund Lars H

Abstract excerpt

BACKGROUND/OBJECTIVES: In heart failure (HF), activation of brain natriuretic peptide (BNP), atrial natriuretic peptide (ANP) and adrenomedullin (ADM) is adaptive. The activation of these peptides in relation to different HF phenotypes such as HF with preserved ejection fraction (HFpEF), reduced ejection fraction (HFrEF) and after left ventricular assist device (LVAD) and heart transplantation (HTx) remains...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Atrial Natriuretic Factor
Share to Heart Failure

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Heart Transplantation

Share to Kaplan-Meier Estimate

Share to Natriuretic Peptide, Brain

Share to Peptide Fragments

Share to Proportional Hazards Models

Share to Stroke Volume

Source

Identifiers

PMID: 25885866
DOI: 10.1016/j.ijcard.2015.03.381

Genes

ADM

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.PMID 25885866Read ↗

Is It the Time to Revolutionize the Heart Failure Management with Emerging Biomarkers and Innovative Targeted Treatments? From Re-Search Evidence to ClinicSemantic proximity Read ↗

Low- and High-renin Heart Failure Phenotypes with Clinical Implications.Semantic proximity Read ↗

Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population.Semantic proximity Read ↗

N-terminal pro-brain natriuretic peptide. a new gold standard in predicting mortality in patients with advanced heart failureSemantic proximity Read ↗

Mechanisms of Disease: β-adrenergic receptors—alterations in signal transduction and pharmacogenomics in heart failureSemantic proximity Read ↗

A State of Natriuretic Peptide DeficiencySemantic proximity Read ↗

β₃-Adrenergic Signaling in Heart Failure: A Stage-Dependent Double-Edged SwordSemantic proximity Read ↗

Older Adults, "Malignant" Left Ventricular Hypertrophy, and Associated Cardiac-Specific Biomarker Phenotypes to Identify the Differential Risk of New-Onset Reduced Versus Preserved Ejection Fraction Heart Failure: CHS (Cardiovascular Health Study).Semantic proximity Read ↗

Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.Semantic proximity Read ↗

Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy.Semantic proximity Read ↗

Atrial Natriuretic Peptide Prohormone Gene Expression: Hormones and Diseases That Upregulate its ExpressionSemantic proximity Read ↗

Transcriptional Signatures of the Right Ventricle in End-Stage Heart FailureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.